Also known as: 24729-96-2, St075182, Dtxsid80860321, Methyl 7-chloro-6,7,8-trideoxy-6-[(1-methyl-4-propylprolyl)amino]-2-o-phosphono-1-thiooctopyranoside, Akos015960484, Ncgc00389304-01

Molecular Formula

C₁₈H₃₄ClN₂O₈PS

Molecular Weight

505.0 g/mol

InChI Key

UFUVLHLTWXBHGZ-UHFFFAOYSA-N

1 2D Structure

2D Structure

2 Identification

2.1 Computed Descriptors

2.1.1 IUPAC Name

[6-[2-chloro-1-[(1-methyl-4-propylpyrrolidine-2-carbonyl)amino]propyl]-4,5-dihydroxy-2-methylsulfanyloxan-3-yl] dihydrogen phosphate

2.1.2 InChI

InChI=1S/C18H34ClN2O8PS/c1-5-6-10-7-11(21(3)8-10)17(24)20-12(9(2)19)15-13(22)14(23)16(18(28-15)31-4)29-30(25,26)27/h9-16,18,22-23H,5-8H2,1-4H3,(H,20,24)(H2,25,26,27)

2.1.3 InChI Key

UFUVLHLTWXBHGZ-UHFFFAOYSA-N

2.1.4 Canonical SMILES

CCCC1CC(N(C1)C)C(=O)NC(C2C(C(C(C(O2)SC)OP(=O)(O)O)O)O)C(C)Cl

2.2 Synonyms

2.2.1 Depositor-Supplied Synonyms

1. 24729-96-2

2. St075182

3. Dtxsid80860321

4. Methyl 7-chloro-6,7,8-trideoxy-6-[(1-methyl-4-propylprolyl)amino]-2-o-phosphono-1-thiooctopyranoside

5. Akos015960484

6. Ncgc00389304-01

7. Ac-11380

8. Methyl7-chloro-6,7,8-trideoxy-6-(1-methyl-trans-4-propyl-l-2-pyrrolidinecarboxamido)-1-thio-l-threo-alpha-d-galacto-octopyranoside2-(dihydrogenphosphate)

9. Db-046536

10. Ft-0603210

2.3 Create Date

2005-08-08

3 Chemical and Physical Properties

Molecular Formula	C₁₈H₃₄ClN₂O₈PS
Molecular Weight	505.0 g/mol
XLogP3	-1.2
Hydrogen Bond Donor Count	5
Hydrogen Bond Acceptor Count	10
Rotatable Bond Count	9
Exact Mass	504.1462019 g/mol
Monoisotopic Mass	504.1462019 g/mol
Topological Polar Surface Area	174 Å²
Heavy Atom Count	31
Formal Charge	0
Complexity	658
Isotope Atom Count	0
Defined Atom Stereocenter Count	0
Undefined Atom Stereocenter Count	9
Defined Bond Stereocenter Count	0
Undefined Bond Stereocenter Count	0
Covalently Bonded Unit Count	1

4 Drug and Medication Information

4.1 Drug Information

1 of 21
Drug Name	CLEOCIN
Active Ingredient	CLINDAMYCIN PHOSPHATE
Company	PHARMACIA AND UPJOHN (Application Number: N050537); PHARMACIA AND UPJOHN (Application Number: N050680); PHARMACIA AND UPJOHN (Application Number: N050767. Patent: 6495157)

2 of 21
Drug Name	CLINDA-DERM
Active Ingredient	CLINDAMYCIN PHOSPHATE
Company	PADDOCK LLC (Application Number: A063329)

3 of 21
Drug Name	CLINDAGEL
Active Ingredient	CLINDAMYCIN PHOSPHATE
Company	PRECISION DERMAT (Application Number: N050782. Patent: 6387383)

4 of 21
Drug Name	CLINDAMYCIN PHOSPHATE IN 0.9% SODIUM CHLORIDE
Active Ingredient	CLINDAMYCIN PHOSPHATE
Company	BAXTER HLTHCARE CORP (Application Number: N208083)

5 of 21
Drug Name	CLINDAMYCIN PHOSPHATE AND BENZOYL PEROXIDE
Active Ingredient	BENZOYL PEROXIDE; CLINDAMYCIN PHOSPHATE
Company	ACTAVIS LABS UT INC (Application Number: A205128); MYLAN PHARMS INC (Application Number: A065443); PERRIGO ISRAEL (Application Number: A090979); PERRIGO ISRAEL (Application Number: A202440); TARO (Application Number: A206218); TOLMAR (Application Number: A203688); TOLMAR (Application Number: A204087)

6 of 21
Drug Name	BENZACLIN
Active Ingredient	BENZOYL PEROXIDE; CLINDAMYCIN PHOSPHATE
Company	VALEANT BERMUDA (Application Number: N050756)

7 of 21
Drug Name	ACANYA
Active Ingredient	BENZOYL PEROXIDE; CLINDAMYCIN PHOSPHATE
Company	DOW PHARM (Application Number: N050819. Patents: 8288434, 8663699, 8895070, 9078870, 9504704, 9561208)

8 of 21
Drug Name	CLEOCIN PHOSPHATE
Active Ingredient	CLINDAMYCIN PHOSPHATE
Company	PHARMACIA AND UPJOHN (Application Number: A062803); PHARMACIA AND UPJOHN (Application Number: N050441)

9 of 21
Drug Name	CLINDAMYCIN PHOSPHATE IN DEXTROSE 5%
Active Ingredient	CLINDAMYCIN PHOSPHATE
Company	ABRAXIS PHARM (Application Number: N050635)

10 of 21
Drug Name	CLINDESSE
Active Ingredient	CLINDAMYCIN PHOSPHATE
Company	PERRIGO PHARMA INTL (Application Number: N050793. Patents: 6899890, 9789057)

11 of 21
Drug Name	ONEXTON
Active Ingredient	BENZOYL PEROXIDE; CLINDAMYCIN PHOSPHATE
Company	DOW PHARM (Application Number: N050819. Patents: 8288434, 8663699, 8895070, 9078870, 9504704, 9561208)

12 of 21
Drug Name	CLINDAMYCIN PHOSPHATE AND TRETINOIN
Active Ingredient	CLINDAMYCIN PHOSPHATE; TRETINOIN
Company	ACTAVIS MID ATLANTIC (Application Number: A202564)

13 of 21
Drug Name	ZIANA
Active Ingredient	CLINDAMYCIN PHOSPHATE; TRETINOIN
Company	MEDICIS (Application Number: N050802. Patent: 6387383)

14 of 21
Drug Name	EVOCLIN
Active Ingredient	CLINDAMYCIN PHOSPHATE
Company	MYLAN PHARMS INC (Application Number: N050801. Patents: 7141237, 7374747)

15 of 21
Drug Name	CLINDETS
Active Ingredient	CLINDAMYCIN PHOSPHATE
Company	PERRIGO CO (Application Number: A064136)

16 of 21
Drug Name	DUAC
Active Ingredient	BENZOYL PEROXIDE; CLINDAMYCIN PHOSPHATE
Company	STIEFEL (Application Number: N050741)

17 of 21
Drug Name	VELTIN
Active Ingredient	CLINDAMYCIN PHOSPHATE; TRETINOIN
Company	AQUA PHARMS LLC (Application Number: N050803)

18 of 21
Drug Name	CLEOCIN PHOSPHATE IN DEXTROSE 5% IN PLASTIC CONTAINER
Active Ingredient	CLINDAMYCIN PHOSPHATE
Company	PHARMACIA AND UPJOHN (Application Number: N050639)

19 of 21
Drug Name	CLEOCIN T
Active Ingredient	CLINDAMYCIN PHOSPHATE
Company	PHARMACIA AND UPJOHN (Application Number: N050537); PHARMACIA AND UPJOHN (Application Number: N050600); PHARMACIA AND UPJOHN (Application Number: N050615)

20 of 21
Drug Name	CLINDAMYCIN PHOSPHATE IN 5% DEXTROSE IN PLASTIC CONTAINER
Active Ingredient	CLINDAMYCIN PHOSPHATE
Company	AKORN INC (Application Number: A203048); BAXTER HLTHCARE CORP (Application Number: A208084); SANDOZ INC (Application Number: A201692)

21 of 21
Drug Name	CLINDAMYCIN PHOSPHATE
Active Ingredient	CLINDAMYCIN PHOSPHATE
Company	AKORN (Application Number: A065513); ALVOGEN INC (Application Number: A062800); ALVOGEN INC (Application Number: A062801); ALVOGEN INC (Application Number: A062943); FOUGERA PHARMS INC (Application Number: A064159); FOUGERA PHARMS (Application Number: A064160); FOUGERA PHARMS (Application Number: A065067); FOUGERA PHARMS (Application Number: A065139); FOUGERA PHARMS (Application Number: A065254); FRESENIUS KABI USA (Application Number: A065346); FRESENIUS KABI USA (Application Number: A065347); G AND W LABS INC (Application Number: A062811); GLASSHOUSE PHARMS (Application Number: A209846); MYLAN LABS LTD (Application Number: A204748); MYLAN LABS LTD (Application Number: A204749); PERRIGO NEW YORK (Application Number: A064050); PERRIGO NEW YORK (Application Number: A065049); PERRIGO UK FINCO (Application Number: A090785); SAGENT PHARMS (Application Number: A090108); SAGENT PHARMS (Application Number: A090109); TARO PHARM INDS (Application Number: A065184); TELIGENT PHARMA INC (Application Number: A206945); VINTAGE PHARMS (Application Number: A203343); WEST-WARD PHARMS INT (Application Number: A062889); WEST-WARD PHARMS INT (Application Number: A065206); WOCKHARDT (Application Number: A063304)

Privacy policy
Terms and conditions
Disclaimers
Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

St075182

St075182

ACCESS ALL DATA

CHEMISTRY

Discover Molecule Insights

Filters